Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nandini Menon

Showing results (41-50 of 166) with videos related to

Pageof 17
Sort By:
South Asian Journal of Cancer|November 16, 2023
Long-Term Outcomes of Crizotinib Treated ALK-Positive Lung Cancer Patients: A Retrospective Audit of Prospective Data from Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Journal of the Egyptian National Cancer Institute|July 27, 2025
Nutritional status and impact on outcomes of patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: a pre-planned secondary analysis of a phase 3 randomized controlled trialVanita Noronha, Avani Chawda, Vijay Patil, et al.
Oral Oncology|September 24, 2021
Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trialNandini Menon, Vijay Patil, Vanita Noronha, et al.
Ecancermedicalscience|September 8, 2022
ALK-positive advanced non-small cell lung cancer patients with poor performance status: Outcomes in a real-world scenarioAjaykumar Singh, Akhil Kapoor, Vanita Noronha, et al.
Oral Oncology|September 20, 2022
Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancerVijay Patil, Sravan Kumar, Vanita Noronha, et al.
Ecancermedicalscience|February 25, 2022
Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)Lakhan Kashyap, Vijay Patil, Vanita Noronha, et al.
Journal of Neuro-Oncology|February 20, 2026
Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control studyRahat Malhotra, Prithwijit Moitra, Abhishek Chatterjee, et al.
South Asian Journal of Cancer|January 2, 2023
Prognostic Impact of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A Retrospective ReviewSatvik Khaddar, Akhil Kapoor, Vanita Noronha, et al.
South Asian Journal of Cancer|February 9, 2023
Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 InhibitorsAkhil Kapoor, Vanita Noronha, Vijay M Patil, et al.
Journal of Geriatric Oncology|March 14, 2022
G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancerMinit Shah, Vanita Noronha, Anant Ramaswamy, et al.
Pageof 17

Showing results (41-50 of 166) with videos related to

Sort By:
Pageof 17
South Asian Journal of Cancer|November 16, 2023
Long-Term Outcomes of Crizotinib Treated ALK-Positive Lung Cancer Patients: A Retrospective Audit of Prospective Data from Resource-Constrained SettingsAkhil Kapoor, Vanita Noronha, Vijay Patil, et al.
Journal of the Egyptian National Cancer Institute|July 27, 2025
Nutritional status and impact on outcomes of patients with locally advanced head and neck squamous cell carcinoma treated with concurrent chemoradiotherapy: a pre-planned secondary analysis of a phase 3 randomized controlled trialVanita Noronha, Avani Chawda, Vijay Patil, et al.
Oral Oncology|September 24, 2021
Quality of life in patients with locally advanced head and neck cancer treated with concurrent chemoradiation with cisplatin and nimotuzumab versus cisplatin alone - Additional data from a phase 3 trialNandini Menon, Vijay Patil, Vanita Noronha, et al.
Ecancermedicalscience|September 8, 2022
ALK-positive advanced non-small cell lung cancer patients with poor performance status: Outcomes in a real-world scenarioAjaykumar Singh, Akhil Kapoor, Vanita Noronha, et al.
Oral Oncology|September 20, 2022
Long term outcomes of a randomized controlled clinical trial comparing the efficacy of Cabazitaxel versus docetaxel as second-line or above therapy in recurrent head and neck cancerVijay Patil, Sravan Kumar, Vanita Noronha, et al.
Ecancermedicalscience|February 25, 2022
Efficacy and safety of neoadjuvant chemotherapy (NACT) with paclitaxel plus carboplatin and oral metronomic chemotherapy (OMCT) in patients with technically unresectable oral squamous cell carcinoma (OSCC)Lakhan Kashyap, Vijay Patil, Vanita Noronha, et al.
Journal of Neuro-Oncology|February 20, 2026
Clinical and genetic predictors of temozolomide-induced severe myelotoxicity in adult diffuse glioma: a case-control studyRahat Malhotra, Prithwijit Moitra, Abhishek Chatterjee, et al.
South Asian Journal of Cancer|January 2, 2023
Prognostic Impact of Baseline Liver Metastasis in ALK Fusion-Positive Metastatic Lung Cancer: A Retrospective ReviewSatvik Khaddar, Akhil Kapoor, Vanita Noronha, et al.
South Asian Journal of Cancer|February 9, 2023
Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 InhibitorsAkhil Kapoor, Vanita Noronha, Vijay M Patil, et al.
Journal of Geriatric Oncology|March 14, 2022
G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancerMinit Shah, Vanita Noronha, Anant Ramaswamy, et al.
Pageof 17